SecSonar.com

Lucid Diagnostics Inc. (LUCD)

Lucid Diagnostics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Lucid Diagnostics Inc. (LUCD) is a Medical - Devices company based in US with a market capitalization of $108.4M. Revenue grew 8.3% year-over-year and free cash flow was negative at -$46.5B. This page tracks LUCD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 72 employees · IPO Oct 14, 2021

Valuation

Valuation & price

$0.99 · as of May 17, 2026 · -32.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

9.92

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.47$1.21$0.96Jul 25Dec 25Jul 26Jul 7, 25$1.04Jul 9, 25$1.12Jul 11, 25$1.14Jul 15, 25$1.17Jul 17, 25$1.14Jul 21, 25$1.11Jul 23, 25$1.12Jul 25, 25$1.11Jul 29, 25$1.08Jul 31, 25$0.98Aug 4, 25$1.02Aug 6, 25$0.99Aug 11, 25$1.00Aug 13, 25$0.98Aug 15, 25$1.02Aug 19, 25$0.99Aug 21, 25$1.05Aug 25, 25$1.16Aug 27, 25$1.26Aug 29, 25$1.26Sep 3, 25$1.24Sep 5, 25$1.37Sep 9, 25$1.27Sep 11, 25$1.07Sep 16, 25$1.07Sep 18, 25$1.07Sep 22, 25$1.08Sep 24, 25$1.04Sep 26, 25$1.03Sep 30, 25$1.01Oct 2, 25$1.02Oct 6, 25$1.03Oct 8, 25$1.22Oct 10, 25$1.15Oct 14, 25$1.19Oct 16, 25$1.23Oct 21, 25$1.21Oct 23, 25$1.23Oct 27, 25$1.26Oct 29, 25$1.25Oct 31, 25$1.21Nov 4, 25$1.11Nov 6, 25$1.07Nov 10, 25$1.05Nov 12, 25$1.11Nov 14, 25$1.07Nov 18, 25$1.05Nov 20, 25$1.02Nov 25, 25$1.09Nov 28, 25$1.06Dec 2, 25$1.01Dec 4, 25$1.06Dec 8, 25$1.05Dec 10, 25$1.14Dec 12, 25$1.16Dec 16, 25$1.12Dec 18, 25$1.13Dec 22, 25$1.13Dec 24, 25$1.11Dec 29, 25$1.07Jan 2, 26$1.12Jan 6, 26$1.13Jan 8, 26$1.23Jan 12, 26$1.19Jan 14, 26$1.24Jan 16, 26$1.21Jan 21, 26$1.13Jan 23, 26$1.21Jan 27, 26$1.22Jan 29, 26$1.14Feb 2, 26$1.28Feb 4, 26$1.20Feb 9, 26$1.23Feb 11, 26$1.20Feb 13, 26$1.33Feb 18, 26$1.34Feb 20, 26$1.36Feb 24, 26$1.46Feb 26, 26$1.47Mar 2, 26$1.45Mar 4, 26$1.45Mar 6, 26$1.40Mar 10, 26$1.41Mar 12, 26$1.39Mar 17, 26$1.38Mar 19, 26$1.28Mar 23, 26$1.25Mar 25, 26$1.19Mar 27, 26$1.12Mar 31, 26$1.15Apr 2, 26$1.14Apr 7, 26$1.12Apr 9, 26$1.15Apr 13, 26$1.28Apr 15, 26$1.41Apr 17, 26$1.25Apr 22, 26$1.31Apr 24, 26$1.07Apr 28, 26$1.04Apr 30, 26$1.07May 4, 26$1.09May 6, 26$1.08May 8, 26$1.03May 12, 26$1.04May 14, 26$1.02May 18, 26$0.96May 20, 26$1.00May 22, 26$1.07May 28, 26$1.05Jun 1, 26$1.03Jun 3, 26$1.00Jun 5, 26$0.97Jun 9, 26$0.99Jun 11, 26$0.98Jun 15, 26$1.00Jun 17, 26$0.98Jun 22, 26$1.03Jun 24, 26$1.02Jun 26, 26$1.08Jul 2, 26$1.07
$0.9552-week range$1.47
Loading valuation history…

Fundamentals

Key fundamentals

$108.4M

Market cap

8.3%

Revenue growth (YoY)

-60.3%

Gross margin

-$46.5B

Free cash flow (USD)

-$8.9M

Net debt

Net cash position

101.8%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$500.0KFY 2022$377.0KFY 2023$2.4MFY 2024$4.3MFY 2025$4.7M
$0$4.7M

Free cash flow by year

2018 → 2025

FY 2018$-113.7KFY 2019$-2.4MFY 2020$-5.6MFY 2021$-18.5MFY 2022$-30.6MFY 2023$-33.0MFY 2024$-44.8MFY 2025$-46.5B
-$113.7K-$46.5B

Gross margin by year

2021 → 2025

FY 2021-17.0%FY 2022-858.6%FY 2023-249.2%FY 2024-90.2%FY 2025-60.3%
-17.0%-60.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.07)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 24, 2026Filing
  • Insider buyInsider Buy $245KMatheis Dennis · Director · $245.3KMay 21, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventStock Offering ClosedApr 24, 2026Filing
  • 8-K eventStock OfferingApr 23, 2026Filing

Questions

Frequently asked questions

What is Lucid Diagnostics Inc.'s market cap?

Lucid Diagnostics Inc. (LUCD) has a market capitalization of $108.4M.

What is LUCD's P/E ratio?

A meaningful P/E ratio is not available for LUCD — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is LUCD's price-to-book (P/B) ratio?

LUCD trades at 9.92 times book value per share.

When did Lucid Diagnostics Inc. last report earnings?

LUCD last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying LUCD stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Lucid Diagnostics Inc. in the last 90 days.

Same arena

Related companies in Medical - Devices

RCEL

AVITA Medical, Inc.

$106.8M

HSDT

Solana Company

$111.8M

OWLT

Owlet, Inc.

$101.9M

FONR

FONAR Corporation

$117.6M

RPID

Rapid Micro Biosystems, Inc.

$91.6M

OM

Outset Medical, Inc.

$91.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.